Literature DB >> 12515327

Participation of the cholinergic system in the excessive grooming behavior induced by neuropeptide (N) glutamic acid (E) isoleucine (I) amide (NEI).

Victoria Berberian1, Mónica Silvina Sanchez, María Ester Celis.   

Abstract

The neuropeptide (N) glutamic acid (E) isoleucine (I) amide (NEI) injected into the ventral tegmental area (VTA) or intraventricularly (icv) induces excessive grooming behavior (EGB) and motor activity (MA). Here, we studied whether the cholinergic system is involved in the NEI-induced behavior. The present results demonstrate that atropine, a general muscarinic antagonist, injected icv previous to NEI, suppresses the behavior provoked by icv injections of the peptide, whereas the prior icv injection of dyhidro-beta-erythroidine, a general nicotinic antagonist, did not affect the EGB and MA induced by the peptide. From the experimental evidence, it is suggested that NEI may act specifically on a cholinergic afferent to dopaminergic cells. Also, the results appear to indicate that a neural target, different from the dopamine system, may be activated by the peptide to elicit behavioral changes, such as EGB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515327     DOI: 10.1023/a:1021655631754

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  29 in total

Review 1.  Melanin-concentrating hormone: a general vertebrate neuropeptide.

Authors:  B I Baker
Journal:  Int Rev Cytol       Date:  1991

2.  The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: structure-activity studies.

Authors:  W H Gispen; V M Wiegant; H M Greven; D de Wied
Journal:  Life Sci       Date:  1975-08-15       Impact factor: 5.037

3.  Organization of ascending hypothalamic projections to the rostral forebrain with special reference to the innervation of cholinergic projection neurons.

Authors:  W E Cullinan; L Záborszky
Journal:  J Comp Neurol       Date:  1991-04-22       Impact factor: 3.215

4.  Hypothalamic axons terminate on forebrain cholinergic neurons: an ultrastructural double-labeling study using PHA-L tracing and ChAT immunocytochemistry.

Authors:  L Zaborszky; W E Cullinan
Journal:  Brain Res       Date:  1989-02-06       Impact factor: 3.252

Review 5.  Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation.

Authors:  P B Clarke
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

6.  Nicotinic receptors in mammalian brain.

Authors:  M Williams; J L Robinson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1984       Impact factor: 5.067

7.  Melanin-concentrating hormone in human and rat.

Authors:  K Takahashi; H Suzuki; K Totsune; O Murakami; F Satoh; M Sone; H Sasano; T Mouri; S Shibahara
Journal:  Neuroendocrinology       Date:  1995-05       Impact factor: 4.914

8.  Behavioral effects of neuropeptide E-I (NEI) in the female rat: interactions with alpha-MSH, MCH and dopamine.

Authors:  M I Gonzalez; B I Baker; D R Hole; C A Wilson
Journal:  Peptides       Date:  1998       Impact factor: 3.750

9.  Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors.

Authors:  M G Lacey; P Calabresi; R A North
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

10.  Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats.

Authors:  C D Blaha; P Winn
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

View more
  1 in total

1.  Integrated 16S rRNA sequencing and metabolomics analysis to investigate the antidepressant role of Yang-Xin-Jie-Yu decoction on microbe-gut-metabolite in chronic unpredictable mild stress-induced depression rat model.

Authors:  Xing-Qiu Liang; Peng-Yu Mai; Hui Qin; Sen Li; Wen-Juan Ou; Jian Liang; Jing Zhong; Ming-Kun Liang
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.